Enalapril maleate and a lysine analogue (MK-521): disposition in man.-Reference-Cited by-同舟云学术

Enalapril maleate and a lysine analogue (MK-521): disposition in man.

Published:1982-09 Issue:3 Volume:14 Page:357-362
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Ulm EH,Hichens M,Gomez HJ,Till AE,Hand E,Vassil TC,Biollaz J,Brunner HR,Schelling JL

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1982.tb01991.x/fullpdf

Reference15 articles.

1. Three new long-acting converting-enzyme inhibitors: Relationship between plasma converting-enzyme activity and response to angiotensin I.;BIOLLAZ;Clin. Pharmac. Ther.,1981

2. Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between serum drug levels and the renin angiotensin system.;BIOLLAZ;Br. J. clin. Pharmac.,1982

3. Effect of a new angiotensin converting-enzyme inhibitor MK-421 and its lysine analogue on the components of the renin system in healthy subjects.;BRUNNER;Br. J. clin. Pharmac.,1981

4. Antihypertensive effect of a new angiotensin converting enzyme inhibitor MK-421.;GAVRAS;Lancet,1981

5. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-ala-L-pro and its ethyl est (MK-421) on angiotensin converting enzyme in vitro and angiotensin pressor responses in vivo.;GROSS;J. Pharmac. exp. Ther.,1981

Cited by 223 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefit and risk evaluation of quinapril hydrochloride;Expert Opinion on Drug Safety;2023-04-03

2. Renin–angiotensin–aldosterone pathway modulators in chronic kidney disease: A comparative review;Frontiers in Pharmacology;2023-02-13

3. Bioequivalence evaluation and food effect assessment of Lisinopril/amlodipine tablets in healthy Chinese subjects under fasting and fed conditions;BMC Pharmacology and Toxicology;2022-07-07

4. Enalapril and Enalaprilat Pharmacokinetics in Children with Heart Failure Due to Dilated Cardiomyopathy and Congestive Heart Failure after Administration of an Orodispersible Enalapril Minitablet (LENA-Studies);Pharmaceutics;2022-05-30

5. Heart failure as a risk factor of adverse drug reactions. Part 2: potential changes in pharmacokinetics of some drugs;Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice;2022-02-13